myirislogo
02 July, 2015 23:46 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 267.40 0.07
Icici Bank 312.95 0.26
Hindalco In 111.15 1.72
Reliance 1010.30 0.45
Tata Stl 304.40 0.70
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Nectar Lifesciences Limited
Nectar Lifesciences Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:532649NSE:NECLIFEBloomberg:NLSC@INReuters:NECT.BO
Market Lot: 1Face Value: 1ISIN Demat: INE023H01027
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
14-MAY-15 Nectar Lifesciences (NecLife) has received ANVISA cGMP (current Good Manufacturing Practices) approval for Brazil for its Cephalosporin APIs manufacturing facility in Dera Bassi , Punjab. The regulatory authority concluded that the facility, systems and practices comply with ANVISA cGMP requirements. 03-MAR-15 Nectar Lifesciences, the fast-growing manufacture of generic pharmaceutical active pharmaceutical ingredients (APIs) and for...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
NecLife gets ANVISA Brazil cGMP approval for Cephalosporin API's facility  -IRIS 14-May-15
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Dec-2014(9)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 12194.3116377.6916248.14
Other Income71.82116.28160.40
Total Income12266.1316493.9716408.54
Cost of goods sold10090.1813495.4413361.70
OPBDIT2175.952998.533046.84
PAT495.53620.80856.66
Gross Block---
Equity capital224.26224.26224.26
EPS (Rs.)-2.773.82
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-3.48 - 9.123.94 - 6.79
Debt / Equity (x)---
Operating margin (% of OI)17.718.218.6
Net margin (% of OI) 4.0 3.8 5.2
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Village Saidpura
Tehsil Derabassi
S A S Nagar
Mohali
Punjab-- - -
PHONE
(01762) 3080 00/ 01
FAX
(01762) 2811 87
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer